| Property | Value |
|---|
|
?:abstract
|
-
BACKGROUND: Healthcare services were faced with unprecedented challenges due to the COVID-19 pandemic and its associated lockdown regulations In order to analyse the influence of the pandemic on the healthcare of patients with chronic hepatitis C in Germany, we carried out a structured questionnaire among all centres participating in the German Hepatitis C-Registry (DHC-R) METHODS: 320 centres of the DHC-R were invited to participate in an online survey Of these, 74 centres had included ≥ 5 patients in the last 12 months FINDINGS: A fully answered questionnaire was sent back by 64 centres Due to the lockdown regulations, 11 % of the centres had stopped their regular consultation between March and May 2020;58 % had reduced the consultations and 32 % did not change the consultations More than 50 % of the appointment cancellations were done by the patients 52 % of the centres offered a new or additional telephone consultation and 17 % offered a new video consultation Between March and May 2020, the number of patients newly treated with antivirals was markedly lower when compared with the same period in 2019 All centres had returned to their usual consultation procedures in July 2020 Almost 80 % indicated that there were no significant limitations in patient\'s healthcare However, 22 % of the centres stated that liver decompensation was diagnosed late and 9 4 % stated that diagnosis of hepatocellular carcinoma was delayed An adequate amount of personal protective equipment (including disinfectants) was available in 56 % of the centres Official information by public healthcare authorities was considered sufficient by 63 % of the centres SUMMARY: Diagnosis, therapy and monitoring of patients with chronic hepatitis C were impaired during the COVID-19 pandemic Nevertheless, the majority of the centres did not see healthcare problems for these patients in the medium and long term However, the fact that the diagnosis of liver decompensations with potential lethal consequences was delayed in a considerable number of patients causes major concern
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
[Problems in treating patients with chronic HCV infection due to the COVID-19 pandemic and during the lockdown phase in Germany]
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}